56 related articles for article (PubMed ID: 5450719)
1. Problems in producing alloxan diabetes.
Pemberton LB; Manax WG
Surgery; 1970 Aug; 68(2):375-8. PubMed ID: 5450719
[No Abstract] [Full Text] [Related]
2. Suprarenal intraarterial infusion of alloxan and streptozotocin during balloon occlusion of the juxtarenal abdominal aorta: a simple technique for inducing diabetes mellitus in canines with reduced mortality.
Salis AI; Peterson RG; Stecker MS; Patel NH; Willis LR; Galley P; Eclavea AC; Dreesen RG
Acad Radiol; 2001 Jun; 8(6):473-7. PubMed ID: 11394539
[TBL] [Abstract][Full Text] [Related]
3. [Improved means of reproducing alloxan diabetes in dogs].
Bondarenko MF; Azarian GP; Bobkov IuI; Leont'eva GV
Probl Endokrinol (Mosk); 1978; 24(6):82-4. PubMed ID: 724679
[No Abstract] [Full Text] [Related]
4. [Chemically induced (streptozotocin-alloxan) diabetes mellitus in dogs].
Liu S; Wang W; Luo XM; Ye B
Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):125-8. PubMed ID: 12212196
[TBL] [Abstract][Full Text] [Related]
5. Mortality and renal failure in the streptozocin-alloxan diabetic dog attributed to contamined alloxan preparations.
Cutfield R; Albu DS; Chan IF; Moatamed F; Peric-Golia L; Wilson DE
Horm Metab Res; 1984 Oct; 16(10):549-50. PubMed ID: 6500490
[No Abstract] [Full Text] [Related]
6. The effect of alloxan upon canine exocrine pancreatic secretion.
Tiscornia OM; Janowitz HD; Dreiling DA
Am J Gastroenterol; 1968 Apr; 49(4):328-40. PubMed ID: 5650746
[No Abstract] [Full Text] [Related]
7. A double balloon catheter technique for alloxan diabetogenesis in the dog.
Wigness BD; Mauer SM; Rupp WM; Rohde TD; Steffes MW; Blackshear PJ; Rucker RD; Jeraj K; Buchwald H
Surg Gynecol Obstet; 1982 Dec; 155(6):860-4. PubMed ID: 7147169
[TBL] [Abstract][Full Text] [Related]
8. Production and study of experimental diabetes in mice with alloxan.
Bhaveja UK; Aurora AL; Agarwal DS
Indian J Pathol Microbiol; 1982 Jan; 25(1):1-5. PubMed ID: 7106904
[No Abstract] [Full Text] [Related]
9. [Morphology of the skeletal musculature in alloxan diabetes].
Titova GP; Khotenashvili NV
Biull Eksp Biol Med; 1988 Apr; 105(4):504-6. PubMed ID: 3359041
[No Abstract] [Full Text] [Related]
10. An ultrastructural study of the effect of a diabetogenic dose of alloxan on the secretory ameloblasts of the rat incisor.
Karim AC
Am J Anat; 1983 Jan; 166(1):83-98. PubMed ID: 6837481
[No Abstract] [Full Text] [Related]
11. Suppression of allergic inflammatory response in the skin of alloxan-diabetic rats: relationship with reduced local mast cell numbers.
de F Carvalho V; Campos LV; Farias-Filho FA; Florim LT; Barreto EO; Pirmez C; Savino W; Martins MA; e Silva PM
Int Arch Allergy Immunol; 2008; 147(3):246-54. PubMed ID: 18594156
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.
Bae SK; Kim JY; Yang SH; Kim JW; Kim T; Lee MG
Life Sci; 2006 Apr; 78(20):2287-94. PubMed ID: 16288785
[TBL] [Abstract][Full Text] [Related]
13. [The effect of the treatment of diabetes mellitus on the development of cardiac changes in alloxan diabetes].
Pog'atsa G; Bihari-Varga M; Szinay G
Orv Hetil; 1980 Jan; 121(2):91-4. PubMed ID: 6768045
[No Abstract] [Full Text] [Related]
14. Te effect of continuous low-level gamma radiation on alloxan-induced lethality in mice.
Watson JA; Doolittle DP
Radiat Res; 1967 Sep; 32(1):176-82. PubMed ID: 6053862
[No Abstract] [Full Text] [Related]
15. [Protection of the islet apparatus in experimental alloxan diabetes].
Kudriashov BA; Pytel' IuA; Baskakova GM; Sokolova GA; Liapina LA
Patol Fiziol Eksp Ter; 1982; (2):67-70. PubMed ID: 7045785
[No Abstract] [Full Text] [Related]
16. Studies of tissue alloxan uptake.
Bekdik FC; Farmelant MH; Tyson I
J Nucl Med; 1968 Jan; 9(1):31-4. PubMed ID: 5634412
[No Abstract] [Full Text] [Related]
17. Differential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan-induced diabetes mellitus.
Suresh Y; Das UN
Prostaglandins Leukot Essent Fatty Acids; 2006 Mar; 74(3):199-213. PubMed ID: 16412622
[TBL] [Abstract][Full Text] [Related]
18. [Ultrastructural manifestations of early metabolic disorders in the myocardium of dogs with alloxan diabetes].
Lebkova NP; Bondarenko MF; Kolesova OE; Azarian GP
Biull Eksp Biol Med; 1980 May; 89(5):614-7. PubMed ID: 7397346
[TBL] [Abstract][Full Text] [Related]
19. Changes of lipid peroxidation parameters in dogs with alloxan diabetes.
Vajdovich P; Gaál T; Szilágyi A
Acta Physiol Hung; 1993; 81(4):317-26. PubMed ID: 8067247
[TBL] [Abstract][Full Text] [Related]
20. Intestinal glucose uptake in normal, untreated and insulin-treated diabetic dogs.
Alada AR; Falokun PO; Oyebola DD
Afr J Med Med Sci; 2005 Jun; 34(2):147-56. PubMed ID: 16749339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
